注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Surrozen Inc是一家处于临床前阶段的生物制药公司。该公司致力于发现和开发候选药物,以在广泛的器官和组织中选择性调节Wnt通路,Wnt通路是组织修复的关键介质。该公司的候选产品是多特异性、基于抗体的疗法,模拟自然产生的Wnt或R-spondin蛋白的作用,这些蛋白参与Wnt通路的激活和增强。其两项技术,Surrozen Wnt信号激活蛋白(SWAP)和Surrozen Wnt信号增强子组织特异性工程(SWEETS),能够通过产生Wnt和R-海绵蛋白模拟物选择性调节Wnt信号。SWAP分子被设计用来模拟自然产生的Wnt蛋白的活性。SWEETS分子被设计用来放大身体对自然产生的Wnt蛋白的反应。该公司的两个主要候选产品包括SZN-1326和SZN-043。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Craig C. Parker | 61 | 2018 | CEO, President & Director |
Shao-Lee Lin | 56 | 2021 | Independent Director |
Eric H. Bjerkholt | 63 | 2023 | Independent Director |
Mace L. Rothenberg | 66 | 2021 | Independent Director |
Scott L. Friedman | - | 2022 | Member of Scientific Advisors |
Sarah Gillmor Hymowitz | - | 2022 | Member of Scientific Advisors |
Willard H. Dere | 70 | - | Member of Scientific Advisors |
Wen-Chen Yeh | 60 | 2016 | Member of Scientific Advisory Board |
Bart Williams | - | - | Member of Scientific Advisors |
David J. Woodhouse | 53 | 2020 | Independent Chairman of the Board |
Harold Eliot Varmus | - | - | Member of Scientific Advisors |
Mary Haak-Frendscho | 67 | 2021 | Independent Director |
Timothy W. Kutzkey | 48 | 2016 | Independent Director |
Anna Berkenblit | 54 | 2018 | Independent Director |
Christopher Y. Chai | 57 | 2021 | Independent Director |
Calvin Kuo | - | - | Co-Founder & Member of Scientific Advisor |
K. Christopher Garcia | - | - | Co-Founder & Member of Scientific Advisory Board |
Roeland Nusse | 74 | - | Co-Founder & Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核